Patient Group Urges HHS Panel to Push for Oversight of Dx Firms' Marketing Practices | GenomeWeb

By Turna Ray

Citing reports that test developer Myriad Genetics discourages patients from seeking guidance from genetic counselors, a patient advocacy group urged the HHS Secretary's Advisory Committee on Genetics, Health, and Society last week to recommend that federal agencies monitor the unethical marketing practices of diagnostics companies and encourage patients to seek genetic counseling prior to getting tested.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.